课题基金 / 基金详情

STUDY OF THE SAFETY OF LONG TERM TIAGABINE HCL ADMINISTRATION

STUDY OF THE SAFETY OF LONG TERM TIAGABINE HCL ADMINISTRATION
长期服用盐酸替加宾的安全性研究
批准号:
6274910
负责人:
GREGORY Y CHANG
金额:
$3.67万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

GREGORY Y CHANG的其他基金

相关文献

中文摘要
翻译
这是一个开放标签,非比较,附加治疗,扩展研究
英文摘要
This is an open-label, noncomparative, add-on therapy, extension study in patients who have previously participated in a tiagabine HCL epilepsy study. However, during the course of the study concomitant AEDs may be gradually withdrawn so that some patients may be expected to acheive tiagabine HCL monotherapy. This study may be conducted at any site that is conducting or has conducted, tiagabine HCL clinical studies in the United States. THe objective of this study is to determine the safety of tiagabine HCl as chronic therapy for epilepsy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT
SABRIL (VIGABATRIM) VS CARBAMAZEPINE IN PTS W/NON-REFRACTORY COMPLEX SEIZURES
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT